Tag: overall survival

In a 380-patient cohort, preoperative neutrophil, platelet, and monocyte ratios showed no significant link to survival after liver resection for ...

An adjusted cross-trial analysis found teclistamab plus daratumumab was associated with significantly longer progression-free and overall survival and deeper responses ...

A multicenter study found that FH-deficient kidney cancer patients with DNA damage repair gene mutations showed significantly higher response rates ...

A retrospective study of 117 older patients with diffuse large B-cell lymphoma identified age, performance status and serum albumin as ...

A small retrospective study found that metastatic colorectal cancer patients whose tumors carried only rare, non-hotspot RAS or RAF mutations ...

A retrospective study of 112 DLBCL patients found that a composite HALP-LDH score predicted overall survival more accurately than either ...

A prospective Guinean study of 55 patients found that failed urinary drainage in cervical cancer-related obstructive renal failure was linked ...

A study of 73 treatment-naïve patients with HIV-associated Kaposi sarcoma found that baseline blood levels of eotaxin, interleukin-6 and interleukin-8 ...

A retrospective study of 99 patients found that a low preoperative modified Geriatric Nutritional Risk Index, which combines C-reactive protein ...

A retrospective study of 250 patients developed a nomogram using age, EGFR genotype, CYFRA21-1 level, and TKI generation to predict ...

B7-H6 expression on tumor cells and tumor-infiltrating leukocytes is linked to metastasis, lymph node spread and reduced overall survival in ...

A single-center retrospective analysis of 40 patients with relapsed AL amyloidosis found that daratumumab monotherapy produced hematologic responses in 72.5 ...

A Japanese historical cohort study reconstructed progression-free survival of 3.5 months in 75 atezolizumab-treated lung cancer patients from unstructured electronic ...

A retrospective US cohort of 2,694 pancreatic cancer patients found MTAP deletion in 30.5 percent of tumors and consistently lower ...

A prospective study of 48 patients links dual-tracer FDG and FAPI-04 PET/CT measurements to aggressive pathological features and survival in ...

A Phase 3 trial found the next-generation KRAS G12C inhibitor divarasib extended median overall survival to 17.7 months versus 12 ...

A new review finds that combining immune-checkpoint inhibitors with locoregional therapies improves progression-free survival in hepatocellular carcinoma, but overall survival ...

A phase II trial reports 11.9-month median overall survival with CIMAvax-EGF plus nivolumab in previously treated advanced NSCLC, with the ...

A meta-analysis of fourteen retrospective cohorts finds that dynamic skeletal muscle deterioration during hepatocellular carcinoma treatment is associated with an ...

A retrospective Eastern Indian cohort study found that children with ALL who had detectable end-of-induction measurable residual disease had significantly ...